ARTICLE | Distillery Therapeutics
Hepatic
November 9, 2016 9:01 PM UTC
Patient sample and mouse studies suggest inhibiting MLKL could help treat autoimmune hepatitis. In patients with autoimmune hepatitis, liver levels of MLKL were higher than in patients with hepatic st...
BCIQ Company Profiles
BCIQ Target Profiles